Celldex Therapeutics, Inc. Business Operations Contracts & Agreements
15 Contracts & Agreements
- Collaboration Agreements (4 contracts)
- Development Agreements (1)
- Sales Agreements (2)
- Services Agreements (5)
- Settlement Agreements (2)
- Supply Agreements (1)
- Sales Agreement, dated February 26, 2024, by and between Celldex Therapeutics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on February 26, 2024)
- Confidential Settlement Agreement and Mutual Release, dated July 15, 2022 by and between Shareholder Representatives Services LLC, solely in its capacity as Stockholders... (Filed With SEC on July 18, 2022)
- Binding Settlement Term Sheet, dated June 20, 2022 by and between Shareholder Representatives Services LLC, solely in its capacity as Stockholders Representative, and Celldex... (Filed With SEC on June 23, 2022)
- THIRD AMENDED AND RESTATED SUPPLY AGREEMENT (Filed With SEC on November 5, 2014)
- MASTER SERVICES AGREEMENT (Filed With SEC on August 6, 2013)
- CELLDEX THERAPEUTICS, INC. CONTROLLED EQUITY OFFERINGSM AMENDMENT NO. 1 TO SALES AGREEMENT (Filed With SEC on September 24, 2012)
- AMENDMENT TO MASTER SERVICES AGREEMENT (Filed With SEC on November 3, 2011)
- MASTER SERVICES AGREEMENT (Filed With SEC on November 3, 2011)
- SECOND RESTATED COLLABORATION AGREEMENT (Filed With SEC on March 12, 2010)
- COLLABORATION AGREEMENT (Filed With SEC on March 12, 2010)
- Vaccine Adjuvant License and Collaboration Agreement (Filed With SEC on March 2, 2009)
- RESEARCH COLLABORATION AND COMMERCIALIZATION AGREEMENT (Filed With SEC on March 2, 2009)
- Licenseand Development Agreement dated as of April 16, 2008 between Celldex Therapeutics, Inc. and Pfizer Vaccines LLC (Filed With SEC on May 19, 2008)
- Subcontractor Service Agreement No. DPSC03-02246 (Filed With SEC on November 6, 2003)
- Subcontractor Service Agreement No. DPSC02-02257 (Filed With SEC on November 6, 2003)